Detalhe da pesquisa
1.
Method for rapid optimization of recombinant GPCR protein expression and stability using virus-like particles.
Protein Expr Purif
; 133: 41-49, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28263854
2.
Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
Bioorg Med Chem
; 23(4): 770-8, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25600407
3.
Pharmacological characterization of KLYP961, a dual inhibitor of inducible and neuronal nitric-oxide synthases.
J Pharmacol Exp Ther
; 336(2): 468-78, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21036913
4.
Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors.
Bioorg Med Chem Lett
; 21(22): 6888-94, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21986586
5.
KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Mol Pharmacol
; 76(1): 153-62, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19364813
6.
Back to basics: label-free technologies for small molecule screening.
Comb Chem High Throughput Screen
; 11(3): 231-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18336215
7.
Dataset on Galanin Receptor 3 mutants that improve recombinant receptor expression and stability in an agonist and antagonist bound form.
Data Brief
; 12: 603-607, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28540352
8.
differential roles for the E2A activation domains in B lymphocytes and macrophages.
J Immunol
; 180(3): 1694-703, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18209066
9.
Inhibition of inducible nitric oxide synthase expression by a novel small molecule activator of the unfolded protein response.
Curr Chem Genomics
; 2: 1-9, 2008 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20161838